| The role of PARP inhibitors in BRCA mutated pancreatic cancer J Chi, SY Chung, R Parakrama, F Fayyaz, J Jose, MW Saif Therapeutic advances in gastroenterology 14, 17562848211014818, 2021 | 44 | 2021 |
| Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients NN Hakim, J Chi, C Olazagasti, JM Liu Experimental Biology and Medicine 246 (1), 5-9, 2021 | 32 | 2021 |
| Recent advances in immunotherapy for pancreatic cancer J Chi, R Patel, H Rehman, S Goyal, MW Saif J Cancer Metastasis Treat 6, 43, 2020 | 19 | 2020 |
| Evaluating of HPV–DNA ISH as an Adjunct to P16 Testing in Oropharyngeal Cancer J Chi, IR Preeshagul, S Sheikh-Fayyaz, S Teckie, N Kohn, Y Ziemba, ... Future science OA 6 (9), FSO606, 2020 | 18 | 2020 |
| Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis? JM Liu, J Chi Experimental Biology and Medicine 247 (4), 330-337, 2022 | 16 | 2022 |
| The role of olaparib in metastatic pancreatic cancer J Chi, SY Chung, S Prasad, MW Saif Cancer medicine journal 4 (3), 89, 2021 | 12 | 2021 |
| Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged 65 years or older with advanced pancreatic cancer H Rehman, J Chi, N Hakim, SP Goyal, C Olazagasti, J Jose, L Moriarty, ... Therapeutic advances in gastroenterology 13, 1756284820974912, 2020 | 9 | 2020 |
| Ibrutinib‐Induced Vasculitis in a Patient with Metastatic Colon Cancer Treated in Combination with Cetuximab J Chi, J Park, MW Saif Case Reports in Oncological Medicine 2020 (1), 6154213, 2020 | 8 | 2020 |
| Vaccination efficacy in patients with chronic lymphocytic leukemia KY Wang, P Shah, B Skavla, F Fayyaz, J Chi, JM Rhodes Leukemia & Lymphoma 64 (1), 42-56, 2023 | 7 | 2023 |
| Outcomes in patients with hematological malignancies receiving anti-CD20 therapy in the setting of COVID-19 infection CA Lopez, D Chitty, J Chi, W Saif, B Goldberg Blood 136, 8-9, 2020 | 4 | 2020 |
| Malignant struma ovarii with late recurrence harbouring high microsatellite instability SY Chung, J Chi, J Park, V John, N Seetharamu BMJ Case Reports CP 14 (6), e242081, 2021 | 3 | 2021 |
| COVID-19 disease and SARS-CoV-2 vaccination in patients with cancer DA King, J Chi, SP Goyal, MW Saif Archives of pharmacology and therapeutics 3 (1), 5, 2021 | 2 | 2021 |
| COVID-19 Clinical Research J Chi, D Chitty, M Lee, N Hakim, S Lakhani, L Rajdev, X Zhu, MW Saif Journal of cellular signaling 1 (2), 23, 2020 | 2 | 2020 |
| A prospective pilot study of pharmacogenetic-based dosing of 5-fluouracil (5-FU) and irinotecan (IRI) in patients (pts) with gastrointestinal (GI) malignancies. J Chi, N Hakim, H Rehman, L Moriarty, A Maloney, MH Smith, J Jose, ... Journal of Clinical Oncology 38 (15_suppl), e16138-e16138, 2020 | 2 | 2020 |
| Imatinib induced hypopigmentation and neutropenia in a patient with gastric gastrointestinal stromal tumor KY Wang, J Chi, MW Saif Archives of Medical Case Reports 4 (1), 1-5, 2022 | 1 | 2022 |
| Duloxetine (DL) in treatment of oxaliplatin-induced peripheral neuropathy (PN). J Chi, F Fayyaz, SY Chung, J Jose, AW Komorowski, M Dillon, ... Journal of Clinical Oncology 39 (3_suppl), 195-195, 2021 | 1 | 2021 |
| First analysis of same-day pegfilgrastim use with concurrent capecitabine-based regimens in patients with gastrointestinal malignancies MW Saif, N Hakim, J Chi, H Rehman, SP Goyal, C Olazagasti, ... Cancer medicine journal 4 (Suppl 3), 1, 2020 | 1 | 2020 |
| Safety and efficacy of biweekly gemcitabine in combination with capecitabine (GemCap) in elderly and frail patients (pts) with resected pancreatic cancer (PC). N Hakim, J Chi, H Rehman, W Nealon, GB Deutsch, E Newman, ... Journal of Clinical Oncology 38 (15_suppl), 4628-4628, 2020 | 1 | 2020 |
| The role of routine surveillance imaging in detecting oral cavity cancer recurrence in asymptomatic patients. J Chi, SY Chung, CA Lopez, DK Frank, L Pereira, EZ Gabalski, S Teckie, ... Journal of Clinical Oncology 38 (15_suppl), e18561-e18561, 2020 | 1 | 2020 |
| First analysis of same-day pegfilgrastim use with concurrent capecitabine-based regimens in pts with GI malignancies. N Hakim, J Chi, H Rehman, SP Goyal, C Olazagasti, L Moriarty, J Jose, ... Journal of Clinical Oncology 38 (4_suppl), 817-817, 2020 | 1 | 2020 |
